Vaxxinity, Inc. Quarterly Debt-to-equity in % from Q2 2022 to Q4 2023
Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vaxxinity, Inc. quarterly Debt-to-equity history and growth rate from Q2 2022 to Q4 2023.
Vaxxinity, Inc. Debt-to-equity for the quarter ending December 31, 2023 was 119 %, a 159% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Growth (%)
Period
Value
YoY Chg
Change %
Date
Q4 2023
119
+72.9
+159%
Dec 31, 2023
Q3 2023
92.1
+55
+148%
Sep 30, 2023
Q2 2023
72.8
-19
-20.7%
Jun 30, 2023
Q1 2023
58.1
Mar 31, 2023
Q4 2022
45.8
Dec 31, 2022
Q3 2022
37.1
Sep 30, 2022
Q2 2022
91.8
Jun 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.
We use cookies and similar technologies to provide certain features, enhance
the user experience and deliver content that is relevant to your interests.
Depending on their purpose, analysis and marketing cookies may be used in
addition to technically necessary cookies. By clicking on "Agree and
continue", you declare your consent to the use of the aforementioned cookies.
Here
you can make detailed settings or revoke your consent (in part if necessary)
with effect for the future. For further information, please refer to our
Privacy Policy
.